Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Submission based on results from pivotal phase III trial showing all primary endpoints met
The drug will target specific genetic mutations prevalent in certain types of cancers
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
